Trial Profile
Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Mar 2017
Price :
$35
*
At a glance
- Drugs Nepafenac (Primary) ; Ketorolac
- Indications Ocular inflammation
- Focus Adverse reactions
- 03 Mar 2017 Status changed from recruiting to completed.
- 29 Apr 2016 New trial record